Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 321 participants.

Also called NCT04580914

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 321 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04580914
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Canada, France, Germany, Hong Kong SAR China, Italy, Japan, Monaco, Netherlands, Taiwan, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04580914. Allocation not applicable; no masking; primary purpose treatment. Start 2021-04-12 (actual); primary completion 2023-06-21 (actual). Results posted on 2025-01-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
Acronym
NEwTON AF
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Treatment with IntellaNav StablePoint Ablation Catheter
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct04580914
Content hash
b304af583484ac8c18428211939c27610cab35257e107b455733377de3fd8615